Clinical Trial Update: China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT) [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial in China (CSPPT2-CC/CT) recruiting participants with H-type hypertension and MTHFR 677 CC/CT genotype to study primary stroke p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stroke

Snippet

Sponsor: Shenzhen Ausa Pharmed Co.,Ltd | Conditions: Hypertension, MTHFR 677 CC or CT Genotype | Phase 4 | Status: RECRUITING